U.S. imports of proton-pump inhibitor drugs to treat gastrointestinal disease increased 45% in October on a year earlier, a similar rate to that seen for statins and anticonvulsants. Around half the growth in the three months to October 31 vs. the same period a year earlier came from omeprazol... Read more →
United States
中文